Verrica Pharms Drug Patent Portfolio
Verrica Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Verrica Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11147790 | Treatment of cutaneous disorders | 22 Aug, 2038 | Active |
| US11052064 | Compositions, methods and systems for the treatment of cutaneous disorders | 28 May, 2035 | Active |
Latest Legal Activities on Verrica Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Verrica Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 07 Mar, 2024 | US11052064 |
| Letter from FDA or Dept of Agriculture re PTE application | 07 Feb, 2024 | US11052064 |
| Initial letter Re: PTE Application to regulating agency | 06 Dec, 2023 | US11052064 |
| Patent Term Extension Application under 35 USC 156 Filed | 12 Sep, 2023 | US11052064 |
|
Recordation of Patent Grant Mailed
Critical
| 19 Oct, 2021 | US11147790 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 19 Oct, 2021 | US11147790 |
|
Email Notification
Critical
| 30 Sep, 2021 | US11147790 |
|
Issue Notification Mailed
Critical
| 29 Sep, 2021 | US11147790 |
| Dispatch to FDC | 22 Sep, 2021 | US11147790 |
|
Application Is Considered Ready for Issue
Critical
| 22 Sep, 2021 | US11147790 |
| Filing Receipt - Corrected | 15 Sep, 2021 | US11147790 |
|
Email Notification
Critical
| 15 Sep, 2021 | US11147790 |
|
Issue Fee Payment Verified
Critical
| 10 Sep, 2021 | US11147790 |
|
Issue Fee Payment Received
Critical
| 10 Sep, 2021 | US11147790 |
|
Electronic Review
Critical
| 09 Sep, 2021 | US11147790 |
Verrica Pharms's Family Patents
Verrica Pharms Drug List
Given below is the complete list of Verrica Pharms's drugs and the patents protecting them.
1. Ycanth
Ycanth is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11147790 | Treatment of cutaneous disorders |
22 Aug, 2038
(13 years from now)
| Active |
| US11052064 | Compositions, methods and systems for the treatment of cutaneous disorders |
28 May, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ycanth's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List